Product Information
COBENFY STARTER PACK is a brand product labeled by E.R. Squibb & Sons, L.L.C., priced at $30.0707 per EA under NDC 00003520056. Its NADAC has been published 76 times since Apr 23, 2025.
FDA first approved this application on Sep 26, 2024.
Manufacturer
E.R. Squibb & Sons, L.L.C.NDC
00003520056
Classification
Brand
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
New Drug (NDA)
FDA Application
NDA216158FDA Approved
9/26/2024
On Market Since
9/27/2024
Price Statistics
The NADAC for COBENFY STARTER PACK has been published 76 times since Apr 23, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $30.0707 per EA |
|---|---|
| All-time high | $30.3508 (Jul 15, 2026) |
| All-time low | $29.7209 (Sep 17, 2025) |
| 52-week high | $30.3508 |
| 52-week low | $29.7209 |
| Median price | $29.9212 |
| Average price | $30.0148 |
| Largest weekly change | +2.0% (Jan 14, 2026) |
| Weeks tracked | 76 |
| Tracking since | Apr 23, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the xanomeline and trospium chloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
E.R. Squibb & Sons, L.L.C. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
xanomeline and trospium chloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of COBENFY STARTER PACK?
The current National Average Drug Acquisition Cost (NADAC) for COBENFY STARTER PACK, manufactured by E.R. Squibb & Sons, L.L.C., is $30.0707 per EA (NDC 00003520056), effective Sep 30, 2026.
How has the price of COBENFY STARTER PACK changed over time?
Over the history we have for it, the NADAC for COBENFY STARTER PACK has held within roughly two percent of its current level. It has been tracked across 76 weekly CMS publications since Apr 23, 2025.
What are the highest and lowest recorded NADAC prices for COBENFY STARTER PACK?
Since Apr 23, 2025, the NADAC for COBENFY STARTER PACK has ranged from a low of $29.7209 (Sep 17, 2025) to a high of $30.3508 (Jul 15, 2026), with a median of $29.9212 per EA.
Are there cheaper alternatives to COBENFY STARTER PACK?
No other NADAC-published product currently shares the active ingredient and strength of COBENFY STARTER PACK in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures COBENFY STARTER PACK?
COBENFY STARTER PACK (NDC 00003520056) is labeled by E.R. Squibb & Sons, L.L.C., and CMS classifies it as a brand product.